$WOR
WORTHINGTON ENTERPRISES, INC.

2014 Q3 Form 10-Q Financial Statement

#000119312514367842 Filed on October 09, 2014

View on sec.gov

Income Statement

Concept 2014 Q3 2013 Q3
Revenue $862.4M $692.3M
YoY Change 24.57% 3.94%
Cost Of Revenue $732.9M $581.3M
YoY Change 26.07% 1.56%
Gross Profit $129.5M $111.0M
YoY Change 16.71% 18.49%
Gross Profit Margin 15.02% 16.03%
Selling, General & Admin $75.26M $71.54M
YoY Change 5.19% 20.39%
% of Gross Profit 58.11% 64.47%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $20.40M $19.46M
YoY Change 4.83% 29.85%
% of Gross Profit 15.75% 17.54%
Operating Expenses $75.26M $71.54M
YoY Change 5.19% 20.39%
Operating Profit $52.20M $38.64M
YoY Change 35.11% 15.62%
Interest Expense $9.516M $6.240M
YoY Change 52.5% 18.65%
% of Operating Profit 18.23% 16.15%
Other Income/Expense, Net $300.0K $10.90M
YoY Change -97.25% 5350.0%
Pretax Income $70.93M $70.29M
YoY Change 0.92% 37.9%
Income Tax $22.11M $13.93M
% Of Pretax Income 31.17% 19.82%
Net Earnings $44.17M $54.56M
YoY Change -19.04% 60.64%
Net Earnings / Revenue 5.12% 7.88%
Basic Earnings Per Share $0.65 $0.78
Diluted Earnings Per Share $0.63 $0.76
COMMON SHARES
Basic Shares Outstanding 67.57M shares 69.60M shares
Diluted Shares Outstanding 69.74M shares 72.08M shares

Balance Sheet

Concept 2014 Q3 2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $146.9M $121.0M
YoY Change 21.4% 296.72%
Cash & Equivalents $146.9M $121.0M
Short-Term Investments
Other Short-Term Assets $102.6M $73.90M
YoY Change 38.84% 3.94%
Inventory $467.6M $376.7M
Prepaid Expenses
Receivables $484.0M $436.2M
Other Receivables $3.400M $2.400M
Total Short-Term Assets $1.205B $1.010B
YoY Change 19.23% 19.39%
LONG-TERM ASSETS
Property, Plant & Equipment $504.1M $503.9M
YoY Change 0.05% 14.29%
Goodwill $269.4M $213.6M
YoY Change 26.07% 36.3%
Intangibles $153.0M $163.4M
YoY Change -6.33% 65.52%
Long-Term Investments $196.4M $184.4M
YoY Change 6.46% -24.43%
Other Assets $27.26M $17.49M
YoY Change 55.9% -7.47%
Total Long-Term Assets $1.150B $1.083B
YoY Change 6.22% -1.98%
TOTAL ASSETS
Total Short-Term Assets $1.205B $1.010B
Total Long-Term Assets $1.150B $1.083B
Total Assets $2.355B $2.093B
YoY Change 12.5% 7.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $369.3M $311.2M
YoY Change 18.66% 30.82%
Accrued Expenses $60.57M $38.72M
YoY Change 56.42% 0.23%
Deferred Revenue
YoY Change
Short-Term Debt $10.97M $62.19M
YoY Change -82.37% 21.38%
Long-Term Debt Due $101.2M $1.099M
YoY Change 9106.73% -12.5%
Total Short-Term Liabilities $639.8M $504.3M
YoY Change 26.86% 28.41%
LONG-TERM LIABILITIES
Long-Term Debt $554.5M $405.9M
YoY Change 36.59% -0.28%
Other Long-Term Liabilities $74.18M $65.08M
YoY Change 13.98% -6.19%
Total Long-Term Liabilities $628.7M $471.0M
YoY Change 33.47% -1.14%
TOTAL LIABILITIES
Total Short-Term Liabilities $639.8M $504.3M
Total Long-Term Liabilities $628.7M $471.0M
Total Liabilities $1.396B $1.123B
YoY Change 24.34% 10.81%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $865.9M $857.6M
YoY Change
Total Liabilities & Shareholders Equity $2.355B $2.093B
YoY Change 12.5% 15.93%

Cashflow Statement

Concept 2014 Q3 2013 Q3
OPERATING ACTIVITIES
Net Income $44.17M $54.56M
YoY Change -19.04% 60.64%
Depreciation, Depletion And Amortization $20.40M $19.46M
YoY Change 4.83% 29.85%
Cash From Operating Activities $54.50M $94.46M
YoY Change -42.31% 33.05%
INVESTING ACTIVITIES
Capital Expenditures $23.87M $13.35M
YoY Change 78.77% -20.06%
Acquisitions $36.55M -$52.96M
YoY Change -169.02%
Other Investing Activities -$45.10M $66.20M
YoY Change -168.13% 903.03%
Cash From Investing Activities -$69.00M $52.81M
YoY Change -230.67% -621.79%
FINANCING ACTIVITIES
Cash Dividend Paid $10.11M
YoY Change
Common Stock Issuance & Retirement, Net $21.09M $28.32M
YoY Change -25.51% 160.85%
Debt Paid & Issued, Net $302.0K $284.0K
YoY Change 6.34% -35.75%
Cash From Financing Activities -28.70M -77.61M
YoY Change -63.02% 8.65%
NET CHANGE
Cash From Operating Activities 54.50M 94.46M
Cash From Investing Activities -69.00M 52.81M
Cash From Financing Activities -28.70M -77.61M
Net Change In Cash -43.20M 69.66M
YoY Change -162.01% -760.51%
FREE CASH FLOW
Cash From Operating Activities $54.50M $94.46M
Capital Expenditures $23.87M $13.35M
Free Cash Flow $30.63M $81.11M
YoY Change -62.24% 49.39%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
68478141 shares
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
121049000
CY2014Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
958734000
CY2014Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
623038000
CY2014Q3 us-gaap Restructuring Reserve
RestructuringReserve
4404000
CY2014Q3 us-gaap Liabilities Current
LiabilitiesCurrent
639752000
CY2014Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
17836000
CY2014Q3 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
3929000
CY2014Q3 us-gaap Liabilities Fair Value Disclosure Recurring
LiabilitiesFairValueDisclosureRecurring
2634000
CY2014Q3 us-gaap Equity Method Investment Summarized Financial Information Liabilities And Equity
EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity
823878000
CY2014Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-11032000
CY2014Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
369273000
CY2014Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
101182000
CY2014Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
69766000
CY2014Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
655676000
CY2014Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
60569000
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
865869000
CY2014Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
74178000
CY2014Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
554494000
CY2014Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2354696000
CY2014Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
40182000
CY2014Q3 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
2230000
CY2014Q3 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
688671000
CY2014Q3 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
139973000
CY2014Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
10965000
CY2014Q3 us-gaap Minority Interest
MinorityInterest
92865000
CY2014Q3 us-gaap Liabilities
Liabilities
1395962000
CY2014Q3 us-gaap Equity Method Investment Summarized Financial Information Equity Or Capital
EquityMethodInvestmentSummarizedFinancialInformationEquityOrCapital
365152000
CY2014Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
66973000
CY2014Q3 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
413268000
CY2014Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
12954000
CY2014Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3024000
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
146921000
CY2014Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
32947000
CY2014Q3 us-gaap Goodwill
Goodwill
269357000
CY2014Q3 us-gaap Land
Land
15263000
CY2014Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
504140000
CY2014Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
486005000
CY2014Q3 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
1958000
CY2014Q3 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
823878000
CY2014Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
45632000
CY2014Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
217388000
CY2014Q3 us-gaap Equity Method Investments
EquityMethodInvestments
196373000
CY2014Q3 us-gaap Assets Fair Value Disclosure Nonrecurring
AssetsFairValueDisclosureNonrecurring
19644000
CY2014Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
91519000
CY2014Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1127178000
CY2014Q3 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
1958000
CY2014Q3 us-gaap Assets
Assets
2354696000
CY2014Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
23321000
CY2014Q3 us-gaap Equity Method Investment Summarized Financial Information Noncurrent Assets
EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets
291520000
CY2014Q3 us-gaap Inventory Net
InventoryNet
467562000
CY2014Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
237427000
CY2014Q3 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
31749000
CY2014Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
3354000
CY2014Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
153018000
CY2014Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
861580000
CY2014Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
27264000
CY2014Q3 us-gaap Assets Current
AssetsCurrent
1204544000
CY2014Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
138616000
CY2014Q3 wor Equity Method Investment Summarized Financial Information Long Term Debt
EquityMethodInvestmentSummarizedFinancialInformationLongTermDebt
267232000
CY2014Q3 wor Equity Method Investment Summarized Financial Information Receivable From Partner
EquityMethodInvestmentSummarizedFinancialInformationReceivableFromPartner
14195000
CY2014Q3 wor Equity Method Investment Summarized Financial Information Short Term Borrowings
EquityMethodInvestmentSummarizedFinancialInformationShortTermBorrowings
28217000
CY2014Q3 wor Equity Method Investment Summarized Financial Information Long Term Debt Current Maturities
EquityMethodInvestmentSummarizedFinancialInformationLongTermDebtCurrentMaturities
4435000
CY2014Q3 wor Equity Method Investment Summarized Financial Information Other Noncurrent Liabilities
EquityMethodInvestmentSummarizedFinancialInformationOtherNoncurrentLiabilities
18869000
CY2014Q3 wor Equity Method Investment Summarized Financial Information Cash
EquityMethodInvestmentSummarizedFinancialInformationCash
54254000
CY2014Q3 wor Equity Method Investment Summarized Financial Information Other Current Assets
EquityMethodInvestmentSummarizedFinancialInformationOtherCurrentAssets
463909000
CY2014Q3 wor Distributions In Excess Of Investment In Unconsolidated Affiliates
DistributionsInExcessOfInvestmentInUnconsolidatedAffiliates
57772000
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
51385000
CY2013Q2 us-gaap Assets
Assets
2296381000
CY2014Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
944882000
CY2014Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
611271000
CY2014Q2 us-gaap Restructuring Reserve
RestructuringReserve
7029000
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
589663000
CY2014Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
4953000
CY2014Q2 us-gaap Liabilities Fair Value Disclosure Recurring
LiabilitiesFairValueDisclosureRecurring
4879000
CY2014Q2 us-gaap Equity Method Investment Summarized Financial Information Liabilities And Equity
EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity
814132000
CY2014Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3581000
CY2014Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
333744000
CY2014Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
101173000
CY2014Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
71333000
CY2014Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
655963000
CY2014Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
49873000
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
850812000
CY2014Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
76426000
CY2014Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
554790000
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2296381000
CY2014Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
35506000
CY2014Q2 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
4475000
CY2014Q2 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
674488000
CY2014Q2 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
128595000
CY2014Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
10362000
CY2014Q2 us-gaap Minority Interest
MinorityInterest
94070000
CY2014Q2 us-gaap Liabilities
Liabilities
1351499000
CY2014Q2 us-gaap Equity Method Investment Summarized Financial Information Equity Or Capital
EquityMethodInvestmentSummarizedFinancialInformationEquityOrCapital
351468000
CY2014Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
78514000
CY2014Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
11044000
CY2014Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3043000
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
190079000
CY2014Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
32135000
CY2014Q2 us-gaap Goodwill
Goodwill
251093000
CY2014Q2 us-gaap Land
Land
15260000
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
498861000
CY2014Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
493127000
CY2014Q2 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
1284000
CY2014Q2 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
814132000
CY2014Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
43769000
CY2014Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
213848000
CY2014Q2 us-gaap Equity Method Investments
EquityMethodInvestments
179113000
CY2014Q2 us-gaap Assets Fair Value Disclosure Nonrecurring
AssetsFairValueDisclosureNonrecurring
32074000
CY2014Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
90957000
CY2014Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1110132000
CY2014Q2 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
1284000
CY2014Q2 us-gaap Assets
Assets
2296381000
CY2014Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
24272000
CY2014Q2 us-gaap Equity Method Investment Summarized Financial Information Noncurrent Assets
EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets
294001000
CY2014Q2 us-gaap Inventory Net
InventoryNet
410002000
CY2014Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
213173000
CY2014Q2 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
32235000
CY2014Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
5438000
CY2014Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
145993000
CY2014Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
848889000
CY2014Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
22399000
CY2014Q2 us-gaap Assets Current
AssetsCurrent
1198922000
CY2014Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
105872000
CY2014Q2 wor Equity Method Investment Summarized Financial Information Long Term Debt
EquityMethodInvestmentSummarizedFinancialInformationLongTermDebt
268350000
CY2014Q2 wor Equity Method Investment Summarized Financial Information Receivable From Partner
EquityMethodInvestmentSummarizedFinancialInformationReceivableFromPartner
12717000
CY2014Q2 wor Equity Method Investment Summarized Financial Information Short Term Borrowings
EquityMethodInvestmentSummarizedFinancialInformationShortTermBorrowings
40992000
CY2014Q2 wor Equity Method Investment Summarized Financial Information Long Term Debt Current Maturities
EquityMethodInvestmentSummarizedFinancialInformationLongTermDebtCurrentMaturities
4510000
CY2014Q2 wor Equity Method Investment Summarized Financial Information Other Noncurrent Liabilities
EquityMethodInvestmentSummarizedFinancialInformationOtherNoncurrentLiabilities
20217000
CY2014Q2 wor Equity Method Investment Summarized Financial Information Cash
EquityMethodInvestmentSummarizedFinancialInformationCash
52997000
CY2014Q2 wor Equity Method Investment Summarized Financial Information Other Current Assets
EquityMethodInvestmentSummarizedFinancialInformationOtherCurrentAssets
454417000
CY2014Q2 wor Distributions In Excess Of Investment In Unconsolidated Affiliates
DistributionsInExcessOfInvestmentInUnconsolidatedAffiliates
59287000
CY2014 wor Impact To Fair Value Of Derivative Assets And Liabilities As Result Of Recognition On Net Basis
ImpactToFairValueOfDerivativeAssetsAndLiabilitiesAsResultOfRecognitionOnNetBasis
730000
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.76
CY2013Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2482000 shares
CY2013Q3 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
94464000
CY2013Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
69373000 shares
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72083000 shares
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.78
CY2013Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69601000 shares
CY2013Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-486000
CY2013Q3 us-gaap Gross Profit
GrossProfit
110964000
CY2013Q3 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
671000
CY2013Q3 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
284000
CY2013Q3 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
1763000
CY2013Q3 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Before Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax
4820000
CY2013Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2865000
CY2013Q3 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-7655000
CY2013Q3 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
4298000
CY2013Q3 us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
89814000
CY2013Q3 us-gaap Sales Revenue Net
SalesRevenueNet
692291000
CY2013Q3 us-gaap Profit Loss
ProfitLoss
56353000
CY2013Q3 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
4334000
CY2013Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2365000
CY2013Q3 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-436000
CY2013Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-515000
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
70286000
CY2013Q3 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-52957000
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
38638000
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
58439000
CY2013Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
30516000
CY2013Q3 us-gaap Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee
GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
11000000
CY2013Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
4662000
CY2013Q3 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
423481000
CY2013Q3 us-gaap Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net
DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet
3441000
CY2013Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13354000
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
54557000
CY2013Q3 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-1379000
CY2013Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
10937000
CY2013Q3 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
3351000
CY2013Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-486000
CY2013Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
26951000
CY2013Q3 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
5915000
CY2013Q3 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
59634000
CY2013Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
59218000
CY2013Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3780000
CY2013Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
4641000
CY2013Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-8424000
CY2013Q3 us-gaap Interest Expense
InterestExpense
6240000
CY2013Q3 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
5555000
CY2013Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
71540000
CY2013Q3 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
4298000
CY2013Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-481000
CY2013Q3 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
69664000
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13933000
CY2013Q3 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
1469000
CY2013Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
581327000
CY2013Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
19460000
CY2013Q3 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-77605000
CY2013Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0
CY2013Q3 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-51541000
CY2013Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2201000
CY2013Q3 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
52805000
CY2013Q3 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
7647000
CY2013Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
1469000
CY2013Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
40622000
CY2013Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1796000
CY2013Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
779000
CY2013Q3 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1853000
CY2013Q3 wor Restructuring And Other Expense Income
RestructuringAndOtherExpenseIncome
-3997000
CY2013Q3 wor Equity Method Investment Summarized Financial Information Interest Expense
EquityMethodInvestmentSummarizedFinancialInformationInterestExpense
2223000
CY2013Q3 wor Equity Method Investment Summarized Financial Information Depreciation And Amortization
EquityMethodInvestmentSummarizedFinancialInformationDepreciationAndAmortization
10337000
CY2013Q3 wor Estimated Annual Effective Tax Rate For Continuing Operations
EstimatedAnnualEffectiveTaxRateForContinuingOperations
0.289 pure
CY2013Q3 wor Joint Venture Transactions
JointVentureTransactions
142000
CY2013Q3 wor Equity Method Investment Summarized Financial Information Operating Income Loss
EquityMethodInvestmentSummarizedFinancialInformationOperatingIncomeLoss
64540000
CY2013Q3 wor Equity Method Investment Summarized Financial Information Income Tax Expense Benefit
EquityMethodInvestmentSummarizedFinancialInformationIncomeTaxExpenseBenefit
3030000
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.63
CY2014Q3 us-gaap Restructuring Reserve Period Increase Decrease
RestructuringReservePeriodIncreaseDecrease
100000
CY2014Q3 dei Document Type
DocumentType
10-Q
CY2014Q3 dei Entity Registrant Name
EntityRegistrantName
WORTHINGTON INDUSTRIES INC
CY2014Q3 dei Trading Symbol
TradingSymbol
WOR
CY2014Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2171000 shares
CY2014Q3 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2014Q3 us-gaap Derivatives Methods Of Accounting Nonhedging Derivatives
DerivativesMethodsOfAccountingNonhedgingDerivatives
<div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Economic (Non-designated) Hedges</b></font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px; TEXT-INDENT: 4%" align="justify"><font style="FONT-FAMILY: Times New Roman" size="2">We enter into foreign currency contracts to manage our foreign exchange exposure related to inter-company and financing transactions that do not meet the requirements for hedge accounting treatment. We also enter into certain commodity contracts that do not qualify for hedge accounting treatment. Accordingly, these derivative instruments are adjusted to current market value at the end of each period through earnings.</font></p> </div>
CY2014Q3 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
54485000
CY2014Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-8631000
CY2014Q3 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-12752000
CY2014Q3 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
5132000
CY2014Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
67424000 shares
CY2014Q3 dei Document Period End Date
DocumentPeriodEndDate
2014-08-31
CY2014Q3 dei Amendment Flag
AmendmentFlag
false
CY2014Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--05-31
CY2014Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69738000 shares
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.65
CY2014Q3 dei Entity Central Index Key
EntityCentralIndexKey
0000108516
CY2014Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.18
CY2014Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2014Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
87976 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
67567000 shares
CY2014Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1020000
CY2014Q3 us-gaap Restructuring Reserve Accrual Adjustment
RestructuringReserveAccrualAdjustment
243000
CY2014Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-9592000
CY2014Q3 us-gaap Gross Profit
GrossProfit
129507000
CY2014Q3 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
204000
CY2014Q3 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
302000
CY2014Q3 us-gaap Payments Of Dividends
PaymentsOfDividends
10112000
CY2014Q3 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
2867000
CY2014Q3 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Before Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax
1543000
CY2014Q3 us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
88751000
CY2014Q3 us-gaap Unusual Or Infrequent Item Insurance Proceeds
UnusualOrInfrequentItemInsuranceProceeds
10088000
CY2014Q3 us-gaap Sales Revenue Net
SalesRevenueNet
862414000
CY2014Q3 us-gaap Profit Loss
ProfitLoss
48820000
CY2014Q3 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-8049000
CY2014Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2872000
CY2014Q3 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-121000
CY2014Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
51217000
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
70933000
CY2014Q3 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
36550000
CY2014Q3 us-gaap Payments For Restructuring
PaymentsForRestructuring
2968000
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
52202000
CY2014Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
36717000
CY2014Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
20071000
CY2014Q3 us-gaap Other Comprehensive Income Loss Before Reclassifications Before Tax
OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
-8813000
CY2014Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
2830000
CY2014Q3 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
392550000
CY2014Q3 us-gaap Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net
DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet
-413000
CY2014Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
23873000
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
44168000
CY2014Q3 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-1944000
CY2014Q3 us-gaap Derivative Instruments Gain Loss Reclassification From Accumulated Oci To Income Estimated Net Amount To Be Transferred
DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
-189000
CY2014Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11760000
CY2014Q3 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
5000000
CY2014Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
323000
CY2014Q3 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
961000
CY2014Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-9592000
CY2014Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
27924000
CY2014Q3 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
6990000
CY2014Q3 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
59440000
CY2014Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
40189000
CY2014Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4355000
CY2014Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1950000
CY2014Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-535000
CY2014Q3 us-gaap Interest Expense
InterestExpense
9516000
CY2014Q3 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
-3800000
CY2014Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
75255000
CY2014Q3 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
20934000
CY2014Q3 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
5132000
CY2014Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-203000
CY2014Q3 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-43158000
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22113000
CY2014Q3 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
582000
CY2014Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
732907000
CY2014Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
20367000
CY2014Q3 us-gaap Dividends Cash
DividendsCash
12329000
CY2014Q3 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-28685000
CY2014Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0
CY2014Q3 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
555000
CY2014Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
-1020000
CY2014Q3 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-68958000
CY2014Q3 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
265000
CY2014Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
582000
CY2014Q3 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
-1944000
CY2014Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
41890000
CY2014Q3 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
4677000
CY2014Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4652000
CY2014Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
3472000
CY2014Q3 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-5991000
CY2014Q3 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
20071000
CY2014Q3 wor Restructuring And Other Expense Income
RestructuringAndOtherExpenseIncome
-7000
CY2014Q3 wor Equity Method Investment Summarized Financial Information Interest Expense
EquityMethodInvestmentSummarizedFinancialInformationInterestExpense
2162000
CY2014Q3 wor Equity Method Investment Summarized Financial Information Depreciation And Amortization
EquityMethodInvestmentSummarizedFinancialInformationDepreciationAndAmortization
9122000
CY2014Q3 wor Estimated Annual Effective Tax Rate For Continuing Operations
EstimatedAnnualEffectiveTaxRateForContinuingOperations
0.328 pure
CY2014Q3 wor Impact To Fair Value Of Derivative Assets And Liabilities As Result Of Recognition On Net Basis
ImpactToFairValueOfDerivativeAssetsAndLiabilitiesAsResultOfRecognitionOnNetBasis
333000
CY2014Q3 wor Joint Venture Transactions
JointVentureTransactions
107000
CY2014Q3 wor Equity Method Investment Summarized Financial Information Operating Income Loss
EquityMethodInvestmentSummarizedFinancialInformationOperatingIncomeLoss
63479000
CY2014Q3 wor Equity Method Investment Summarized Financial Information Income Tax Expense Benefit
EquityMethodInvestmentSummarizedFinancialInformationIncomeTaxExpenseBenefit
2753000
CY2014Q3 wor Derivative Instruments Gain Loss Reclassification From Accumulated Oci To Income Estimated Net Amount To Be Transferred Tax
DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferredTax
114000

Files In Submission

Name View Source Status
0001193125-14-367842-index-headers.html Edgar Link pending
0001193125-14-367842-index.html Edgar Link pending
0001193125-14-367842.txt Edgar Link pending
0001193125-14-367842-xbrl.zip Edgar Link pending
d787497d10q.htm Edgar Link pending
d787497dex311.htm Edgar Link pending
d787497dex312.htm Edgar Link pending
d787497dex321.htm Edgar Link pending
d787497dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g787497fs_logo.jpg Edgar Link pending
g787497tx_pg22.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wor-20140831.xml Edgar Link completed
wor-20140831.xsd Edgar Link pending
wor-20140831_cal.xml Edgar Link unprocessable
wor-20140831_def.xml Edgar Link unprocessable
wor-20140831_lab.xml Edgar Link unprocessable
wor-20140831_pre.xml Edgar Link unprocessable